
Telma H 40 mg Tablet
Salt Composition: Telmisartan (40mg) + Hydrochlorothiazide (12.5mg)
Expiry Date: 01/2028
Inclusive of all taxes
15 Tablet
About The Product
Arb + Diuretic For Added Fluid Reduction
Telma H 40mg tablet is an antihypertensive combination medication used to treat high blood pressure (hypertension). The medication combines with two active ingredient Telmisartan in (40mg) concentration and Hydrochlorothiazide (12.5mg) concentration.
The medicine work together to help relax blood vessels, making it easier for blood to flow and lowering blood pressure. Always follow doctor's prescription as recommended to administer the dosage correctly and duration of the medication.
Uses
Manage Blood Pressure
Side Effects
Telma H 40mg tablet cause acute or mild symptoms that harm the body in many ways. Always visit the doctor if any of these side effects appear or get worse.
- Fatigue
- Bradycardia
- Gastrointestinal disturbance
- Electrolyte imbalance
- Postural hypotension
- Angioedema and urticaria
- Visual disturbance
- Breathlessness
- Muscle cramp
- Headache
- Dizziness
- Sleepiness
- Ankle swelling
How To Use
- Telma H 40mg tablet taken with or without food by consulting to a healthcare provider.
- Do not overdose the medication to make up for the missed one, just take the next dose on the scheduled time.
- Always follow prescribed dosage and duration as administered by the healthcare professional.
How It Works
Telma H 40mg tablet is an angiotensin II receptor blocker (ARB), a type of antihypertensive medication. It works by blocking the action of angiotensin II, a hormone that causes blood vessels to narrow.
By inhibiting this action, the medicine helps blood vessels relax and widen, leading to reduced blood pressure, improved blood flow, and easier pumping of blood by the heart.
Safety Advice
FAQs
Taken the medicine once daily as prescribed by the healthcare expert.
It should be taken with or without food at the same time everyday to enhance the effectiveness of the medication.
References
- Deppeler, H. P. (1981). Hydrochlorothiazide. In Analytical profiles of drug substances (Vol. 10, pp. 405-441). Academic Press.
- Herman, L. L., Weber, P., & Bashir, K. (2023). Hydrochlorothiazide. In StatPearls [Internet]. StatPearls Publishing.
- Beermann, B., & Groschinsky-Grind, M. (1977). Pharmacokinetics of hydrochlorothiazide in man. European Journal of Clinical Pharmacology, 12(4), 297-303.
- Mann, J. F., Schmieder, R. E., Dyal, L., McQueen, M. J., Schumacher, H., Pogue, J., ... & TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. (2009). Effect of telmisartan on renal outcomes: a randomized trial. Annals of internal medicine, 151(1), 1-10.
- Ontarget Investigators. (2008). Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine, 358(15), 1547-1559.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
